About Abata Therapeutics
Abata Therapeutics is a private company based in Watertown, Massachusetts, incorporated in 2020 in Delaware. It has reported $60,332,894 raised in two offerings on Form D since June 2021. Its chief executive is Samantha Singer.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 14, 2023 | Dec 27, 2023 | $15,332,894target not set | 8 | $1.9M | Debt, Options, Securities on exerciseRule 506(b) | Form D ↗ |
| Jun 4, 2021 | Jun 21, 2021amended Jun 16, 2022 | $45,000,000of $95.0M target | 7 | $6.4M | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Total, two offerings | $60,332,894 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Abata Therapeutics's Form D filed Dec 27, 2023.
SS
Samantha Singer
Chief Executive Officer and director
LD
Leonard Dragone
Executive officer
VO
SS
Stephen Sofen
Executive officer
SL
Sandy Lazzari
Executive officer
SC
NM
Nagesh Mahanthappa
Director
JT
John Trzupek
Executive officer
AC
Abbie Celniker
Director
MF
Mitch Finer
Director
DK
David Kaufman
Director
LK
EM
Ellen Cahir-Mcfarland
Executive officer